Mark Capone

Biography

Mark is an accomplished 35-year life sciences executive, most recently serving as President and CEO of Myriad Genetics which he transformed from a pioneering start-up to one of the largest precision medicine companies in the world. During his 17-year tenure, the company developed and launched more than a dozen reimbursed molecular diagnostics achieving total annual revenues of more than $800 million. Prior to Myriad, he spent 17-years at Eli Lilly and Company in various positions across the entire value chain.

Mark received a Bachelor of Science degree in Chemical Engineering from Penn State University graduating with highest distinction, and a Master of Science degree in (bio)Chemical Engineering and Master of Science in Management from Massachusetts Institute of Technology. He currently serves as President and CEO of Precision Medicine Advisors, LLC, is a non-executive board member of Abcam plc and Dermtech, Inc.